Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited available metadata, the FDA issued a Warning Letter to Arrow Reliance Inc., an animal and veterinary products company, on February 16, 2023. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from this metadata alone. The warning falls under FDA's regulatory authority over animal and veterinary products, though the specific issuing office is not identified in the available information.